BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1309720)

  • 1. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.
    Wessels MR; Haft RF; Heggen LM; Rubens CE
    Infect Immun; 1992 Feb; 60(2):392-400. PubMed ID: 1309720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cpsD, a gene essential for type III capsule expression in group B streptococci.
    Rubens CE; Heggen LM; Haft RF; Wessels MR
    Mol Microbiol; 1993 May; 8(5):843-55. PubMed ID: 8355611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.
    Wessels MR; Rubens CE; Benedí VJ; Kasper DL
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8983-7. PubMed ID: 2554337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
    Marques MB; Kasper DL; Pangburn MK; Wessels MR
    Infect Immun; 1992 Oct; 60(10):3986-93. PubMed ID: 1398910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cpsF and its product CMP-N-acetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in K1 capsular polysaccharide biosynthesis in Escherichia coli.
    Haft RF; Wessels MR; Mebane MF; Conaty N; Rubens CE
    Mol Microbiol; 1996 Feb; 19(3):555-63. PubMed ID: 8830246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.
    Rubens CE; Wessels MR; Heggen LM; Kasper DL
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7208-12. PubMed ID: 2823254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis.
    Tissi L; von Hunolstein C; Bistoni F; Marangi M; Parisi L; Orefici G
    J Med Microbiol; 1998 Aug; 47(8):717-23. PubMed ID: 9877193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.
    Chaffin DO; Mentele LM; Rubens CE
    J Bacteriol; 2005 Jul; 187(13):4615-26. PubMed ID: 15968073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of a region of the group B streptococcus chromosome involved in type III capsule expression.
    Kuypers JM; Heggen LM; Rubens CE
    Infect Immun; 1989 Oct; 57(10):3058-65. PubMed ID: 2550369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B Streptococcus.
    Lewis AL; Cao H; Patel SK; Diaz S; Ryan W; Carlin AF; Thon V; Lewis WG; Varki A; Chen X; Nizet V
    J Biol Chem; 2007 Sep; 282(38):27562-71. PubMed ID: 17646166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of two group B streptococcal virulence factors.
    Rubens CE; Wessels MR; Kuypers JM; Kasper DL; Weiser JN
    Semin Perinatol; 1990 Aug; 14(4 Suppl 1):22-9. PubMed ID: 2173147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci.
    Edwards MS; Wessels MR; Baker CJ
    Infect Immun; 1993 Jul; 61(7):2866-71. PubMed ID: 8514389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells.
    Hulse ML; Smith S; Chi EY; Pham A; Rubens CE
    Infect Immun; 1993 Nov; 61(11):4835-41. PubMed ID: 8406885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of group B streptococci in human serum leads to increased cell surface sialic acid and decreased activation of the alternative complement pathway.
    Platt MW; Correa N; Mold C
    Can J Microbiol; 1994 Feb; 40(2):99-105. PubMed ID: 8019940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci.
    Mancuso G; Tomasello F; von Hunolstein C; Orefici G; Teti G
    Infect Immun; 1994 Jul; 62(7):2748-53. PubMed ID: 8005664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci.
    Wessels MR; Goldberg JB; Moses AE; DiCesare TJ
    Infect Immun; 1994 Feb; 62(2):433-41. PubMed ID: 8300204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A glutamine transport gene, glnQ, is required for fibronectin adherence and virulence of group B streptococci.
    Tamura GS; Nittayajarn A; Schoentag DL
    Infect Immun; 2002 Jun; 70(6):2877-85. PubMed ID: 12010975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon.
    Chaffin DO; Beres SB; Yim HH; Rubens CE
    J Bacteriol; 2000 Aug; 182(16):4466-77. PubMed ID: 10913080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion.
    Gibson RL; Lee MK; Soderland C; Chi EY; Rubens CE
    Infect Immun; 1993 Feb; 61(2):478-85. PubMed ID: 8423076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CMP-N-acetylneuraminic acid synthetase of group B streptococci.
    Haft RF; Wessels MR
    J Bacteriol; 1994 Dec; 176(23):7372-4. PubMed ID: 7961510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.